Induction of a transient graft vs. leukemia effect following unrelated cord blood transplantation
- 1 September 2002
- journal article
- case report
- Published by Wiley in Pediatric Transplantation
- Vol. 6 (4) , 348-351
- https://doi.org/10.1034/j.1399-3046.2002.00215.x
Abstract
Umbilical cord blood (UCB) has become a frequent source of allogeneic hematopoietic stem cells for transplantation. Of theoretical concern is a potential decrease in the graft vs. leukemia (GvL) effect, given the lesser degree of graft vs. host disease (GvHD) with this donor source. We report a case of recurrent acute non‐lymphoblastic leukemia (ANLL) following stem cell transplantation with unrelated mismatched UCB, which responded to the induction of GvHD. The response was documented both morphologically and by evaluation of chimeric engraftment by molecular DNA techniques. In addition, WT‐1, a purported marker of minimal residual disease in acute leukemia, correlated with remission status in this patient. In summary, the GvL effect is seen with allogeneic UCB transplantation and has the potential to be induced along with GvHD.Keywords
This publication has 12 references indexed in Scilit:
- Graft-Versus-Host Disease in Children Who Have Received a Cord-Blood or Bone Marrow Transplant from an HLA-Identical SiblingNew England Journal of Medicine, 2000
- Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated DonorsNew England Journal of Medicine, 1998
- Wilms Tumor Gene (WT1) as a New Marker for the Detection of Minimal Residual Disease in LeukemiaLeukemia & Lymphoma, 1998
- Outcome of Cord-Blood Transplantation from Related and Unrelated DonorsNew England Journal of Medicine, 1997
- Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation into Unrelated RecipientsNew England Journal of Medicine, 1996
- Sex determination of preimplantation embryos by human testis-determining-gene amplificationThe Lancet, 1994
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990
- Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]Blood, 1989
- Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic PhaseAnnals of Internal Medicine, 1988
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979